Showing results (91-100 of 291) with videos related to
Sort By:
Pageof 30
The Journal of Experimental Medicine|May 1, 1994
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59M Parizade, R Arnon, P J Lachmann, et al.Journal of Immunological Methods|August 30, 1992
A cleavable biotinylating agent and its use in protein electroblotsM J Hobart, B A Fernie, P J LachmannClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1993
Peripheral blood mononuclear cells from house dust mite allergic patients produce IL-2 in response to specific allergen challengeS M McHugh, P J Lachmann, P W EwanJournal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3M C Poznansky, P M Clissold, P J LachmannJournal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cellsW Emlen, G Burdick, V Carl, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J LachmannThe Journal of Experimental Medicine|August 1, 1977
C6: synthesis by the liver in vivoM J Hobart, P J Lachmann, R Y CalneCiba Foundation Symposium|January 1, 1986
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animalsP J Lachmann, L Strangeways, A Vyakarnam, et al.Clinical and Experimental Immunology|February 1, 1990
Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitationP A Gatenby, J E Barbosa, P J LachmannClinical and Experimental Immunology|November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugatesA M Montgomery, M G Wing, P J LachmannPageof 30